Journal of Endocrinological Investigation

, Volume 37, Issue 12, pp 1233–1235 | Cite as

Graves’-like orbitopathy: do not forget IgG4-related disease

Opinion

References

  1. 1.
    Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest 37:691–700PubMedCrossRefGoogle Scholar
  2. 2.
    Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed Graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98:1443–1449PubMedCrossRefGoogle Scholar
  3. 3.
    Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves’ orbitopathy in the XXI century. J Endocrinol Invest 36:444–449PubMedGoogle Scholar
  4. 4.
    Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551PubMedCrossRefGoogle Scholar
  5. 5.
    Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V (2010) Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthr Care Res (Hoboken) 62:1312–1318CrossRefGoogle Scholar
  6. 6.
    Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I, Nagayama K, Nakamura H, Kakudo K (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int 59:636–641PubMedCrossRefGoogle Scholar
  7. 7.
    Fonte R, Pirali B, Caramia V, Dionisio R, Lodigiani S, Sibilla L, Rotondi M, Chiovato L (2011) Graves’-like orbitopathy in a patient with chronic autoimmune pancreatitis. Thyroid 21:1389–1392PubMedCrossRefGoogle Scholar
  8. 8.
    Castillo F, Garrity JA, Kravitz DJ (2013) Intractable Graves’ ophthalmopathy? JAMA Ophthalmol 131:269–270PubMedCrossRefGoogle Scholar
  9. 9.
    Tiegs-Heiden CA, Eckel LJ, Hunt CH, Diehn FE, Schwartz KM, Kallmes DF, Salomao DR, Witzig TE, Garrity JA (2014) Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients. Am J Neuroradiol 35:1393–1397PubMedCrossRefGoogle Scholar
  10. 10.
    Stone JH, Khosroshahi A, Deshpande V, Chan JKC, Heathcote JG, Aalberse R, Atsumi A, Bloch DB, Brugge WR, Carruthers MN, Cheuk W, Cornell L, Fernandez-Del Castillo C, Ferry JA, Forcione D, Kloppel G, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani D, Sato Y, Smyrk T, Stone JR, Takahira M, Umehara H, Webster G, Yamamoto M, Yi E, Yoshino T, Zamboni G, Zen Y, Chari S (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthr Rheum 64:3061–3067CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2014

Authors and Affiliations

  1. 1.Endocrine Unit, Department of Clinical and Experimental MedicineUniversity of InsubriaVareseItaly
  2. 2.Fondazione Salvatore Maugeri IRCCS, Unit of Internal Medicine and EndocrinologyUniversity of PaviaPaviaItaly

Personalised recommendations